Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Single-blinded, Randomized Comparison of the Clinical and Angiographic Results With Intravascular Analysis of EverolimuS-Eluting Versus ZoTarolimus-Eluting steNTs for In-Stent Restenosis(ISR) Lesions: Volumetric Analysis With Intravascular Ultrasound(IVUS) : Phase IV Multicenter Trial ( RESTENT-ISR Trial )

NCT01365572 is registered in ClinicalTrials.gov with Korea University Anam Hospital as lead sponsor.

NCT NCT01365572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01365572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Single-blinded, Randomized Comparison of the Clinical and Angiographic Results With Intravascular Analysis of EverolimuS-Eluting Versus ZoTarolimus-Eluting steNTs for In-Stent Restenosis(ISR) Lesions: Volumetric Analysis With Intravascular Ultrasound(IVUS) : Phase IV Multicenter Trial ( RESTENT-ISR Trial )
Lead sponsor
Korea University Anam Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2010
Completion date
March 31, 2012
Enrollment
292 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

in-stent arterial restenosis